SPI Energy Launches Amazon Store for its Expanding Solar4America Branded Product Portfolio
LIVERMORE, CA / ACCESSWIRE / September 7, 2021 / SPI Energy Co., Ltd. (“SPI Energy”…
Month: September 2021
Dosell Consumer Ready for Broad Launch after Successful Pilot Project
STOCKHOLM, SE / ACCESSWIRE / September 07, 2021 / iZafe Group (STO:IZAFE-B) iZafe Group AB…
TokenSociety.io Announces the NFT Entertainment Financing Platform and the Launch of the First Project
“Men of the House” is the first television show pilot to be entirely funded by…
Falcon Gold Receives DTC Eligibility
VANCOUVER, BC / ACCESSWIRE / September 7, 2021 / FALCON GOLD CORP. (FG:TSX-V), (3FA:GR), (FGLDF:OTCQB);…
Dr. Carlos Barba Collaborates on the Third of Three New Articles
The bariatric and general surgeon acted as an expert consultant on the third in a…
Jan Van Deursen is the Subject of a New Professional Profile
The highly-regarded cellular biologist and entrepreneur sat down with a freelance journalist to discuss his…
Wright Solicitors Quantify The Practice Benefits of Zylpha’s eBundling
Aware that Zylpha’s Pay As You Go bundling was a cost effective route to producing…
MYCOM OSI Named as Finalist in the 2021 Leading Lights Awards
LONDON, UK – Sep 7th, 2021 – MYCOM OSI, the leading independent provider of Assurance,…
HUTCHMED Highlights Clinical Data to be Presented at the Upcoming 2021 ESMO Virtual Conference
HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) — HUTCHMED…
Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment
NEW YORK and LONDON, Sept. 07, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ:…
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Tedopi®
Further Strengthens Global Intellectual Property Portfolio for Tedopi®in Non-Small Cell Lung Cancer until 2035 NANTES,…
Roche to present data from industry leading portfolio at ESMO 2021 showing significant progress in early stage and uncommon cancers
First data to be presented from the phase II coopERA Breast Cancer study evaluating neoadjuvant…
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GENEVA, Switzerland September 7, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company…
Bone Therapeutics SA reacts to the press release issued by Hybrigenics
Gosselies, Belgium, 7 September, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell…
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
MARSEILLE, France, Sept. 07, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH; Nasdaq:…
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
Marseille, France, Sept. 07, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH; Nasdaq:…
ProQR Announces Virtual Presentation at EURETINA 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 06, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a…
ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Cambridge, MA (U.S.)…
PCI Biotech: Employee share option scheme
Oslo, 6 September 2021 In accordance with the authorisation granted and the…
Déclaration d’actions et de droits de vote de la société Valneva SE – Août 2021
VALNEVA Déclaration d’actions et de droits de vote – Août 2021 Dénomination sociale : VALNEVAAdresse du…